JK

Jayanta Kumar Mandal

Active Director Designated Partner DIN 00546169
DIN 00546169 First appointment Jul 2006 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 5 historical roles
Total affiliations 7 Since Jul 2006
Shareholding value •••• Premium profile

About Jayanta Kumar Mandal

Data last updated:

Jayanta Kumar Mandal is a Designated Partner at Jsm Innovations Llp (since 2016) and Director at Apdm Pharmaceuticals Private Limited (since 2022). The companies operate in Pharma, Chemicals and Travel and Hospitality. The 2 current companies with reported revenue have a combined latest revenue of ₹12.21 Cr; the largest is Jsm Innovations Llp at ₹8.85 Cr (FY 2023). Earlier, Jayanta Kumar Mandal was a Director at Celestis Pharmaceuticals Private Limited (2014–2023) and Director at Ftf Pharma Private Limited (2013–2014) and 3 more.

DIN 00546169
Primary Designation Designated Partner
Industry Pharma
First Appointment 17 Jul 2006
Oldest Company Age 10 yrs
Largest company Jsm Innovations Llp · ₹8.85 Cr (FY 2023)
Combined revenue ₹12.21 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner18 Jul 20162016₹8.85 Cr (FY 2023)Active
Apdm Pharmaceuticals Private Limited U24100GJ2022PTC132956
Director16 Jun 20222022₹3.36 Cr (FY 2024)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Jun 20142014₹4.3 Lakh (FY 2024)Active
Ftf Pharma Private Limited U24230GJ2012PTC070818
Director27 Sep 20132012₹29.49 Cr (FY 2025)Active
Astron Research Limited U24231GJ2001PLC039545
Director17 Jul 20062001Amalgamated
Director16 Feb 20152015₹2.5 Lakh (FY 2018)Amalgamated
Director24 May 20172017₹6.48 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Jayanta Kumar Mandal

Directorship timeline

Open interactive timeline →
Jsm Innovations Llp
Apdm Pharmaceuticals Private Limited
Celestis Pharmaceuticals Private Limited
Ftf Pharma Private Limited
Premium access

Shareholding and investment profile for Jayanta Kumar Mandal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jayanta Kumar Mandal

Jayanta Kumar Mandal currently holds 2 directorships: Jsm Innovations Llp (Designated Partner, since 18 Jul 2016, revenue ₹8.85 Cr (FY 2023)); Apdm Pharmaceuticals Private Limited (Director, since 16 Jun 2022, revenue ₹3.36 Cr (FY 2024)).

Jayanta Kumar Mandal was first appointed on 17 Jul 2006 as Director at Astron Research Limited. The most recent appointment on record is 16 Jun 2022 at Apdm Pharmaceuticals Private Limited.

The 2 current companies of Jayanta Kumar Mandal that report revenue have a combined latest revenue of ₹12.21 Cr: Jsm Innovations Llp ₹8.85 Cr (FY 2023); Apdm Pharmaceuticals Private Limited ₹3.36 Cr (FY 2024).

Jayanta Kumar Mandal held 5 earlier board appointments: Celestis Pharmaceuticals Private Limited (Director, 23 Jun 2014 to 01 Mar 2023); Ftf Pharma Private Limited (Director, 27 Sep 2013 to 01 Mar 2014); Astron Research Limited (Director, 17 Jul 2006 to 14 Aug 2012); Celestys Pharmaceuticals Private Limited (Director, 16 Feb 2015 to 15 Feb 2017); Lm Manufacturing India Private Limited (Director, 24 May 2017 to 01 Dec 2019).

The current boards of Jayanta Kumar Mandal's companies include Mousumi Jayanta Mandal (Jsm Innovations Llp), Shobhan Mandal (Jsm Innovations Llp), Jaishree Sharma (Apdm Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available